TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07290673: Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers

Sponsor: Samaritan Biologics · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 124 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07290673 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07290673 Rescue Dossier →